Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)

J Am Acad Dermatol. 2016 Feb;74(2):370-1. doi: 10.1016/j.jaad.2015.09.073. Epub 2015 Dec 11.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Alopecia Areata / complications
  • Alopecia Areata / drug therapy*
  • Hair / drug effects*
  • Hair / growth & development
  • Humans
  • Male
  • Nitriles
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / administration & dosage
  • Pyrazoles / therapeutic use*
  • Pyrimidines
  • Skin Pigmentation / drug effects*
  • Vitiligo / complications
  • Vitiligo / drug therapy*

Substances

  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib